Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
agn-195183 (1 trial)
nrx194204 (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Leukemia (Phase 2)
Leukemia, Promyelocytic, Acute (Phase 2)
Lung Neoplasms (Phase 2)
Trials (2 total)
Trial APIs (2 total)